Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBM29 Inhibitors

RBM29 inhibitors represent a class of chemical compounds that target RBM29, a protein involved in RNA metabolism. RBM29, or RNA Binding Motif Protein 29, is part of a larger family of RNA-binding proteins that regulate various aspects of RNA biogenesis, including splicing, transport, and stability. RBM29 contains multiple RNA recognition motifs (RRMs) that facilitate the interaction with specific RNA substrates, influencing RNA structure and function. Inhibitors targeting RBM29 typically function by disrupting its RNA-binding capacity, either through direct interaction with the RRMs or by altering the protein's conformational stability. These interactions can have cascading effects on the processing of pre-mRNA, leading to changes in the expression and splicing patterns of numerous genes. The specificity of RBM29 inhibitors can often depend on their ability to recognize unique structural features within the RRMs or other functional domains of the protein.

The chemical structure of RBM29 inhibitors typically includes moieties designed to interfere with protein-RNA binding. These inhibitors may incorporate heterocyclic compounds, aromatic rings, or polar functional groups that mimic the RNA substrate or destabilize the RNA-protein interface. The mechanism of action is often centered around competitive binding, whereby the inhibitor occupies the RNA-binding site of RBM29, preventing the natural substrate from interacting with the protein. The development of these inhibitors requires careful design to ensure that they can selectively target RBM29 without affecting other RNA-binding proteins with similar motifs. This selectivity is critical for studying the precise role of RBM29 in RNA processing, as it allows for the dissection of its function in various cellular processes such as gene expression regulation and post-transcriptional modifications. Through their ability to modulate RBM29's activity, these inhibitors serve as important tools in molecular biology research, providing insights into the intricate regulatory networks of RNA metabolism.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits transcription factors and can disrupt RNA processing events in which RBM29 may be involved.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with RNA polymerase, possibly affecting the RNA-related functions of RBM29.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II, potentially impacting RBM29's role in RNA processing.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II and III, and can alter transcription processes associated with RBM29.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$317.00
(2)

Inhibits CDK9/cyclin T, affecting transcription elongation which may impact RBM29's function.

ICRF-193

21416-68-2sc-200889
sc-200889A
1 mg
5 mg
$341.00
$927.00
7
(1)

Inhibits topoisomerase II, potentially changing the transcriptional landscape RBM29 engages with.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Inhibits CRM1/exportin 1, potentially affecting RBM29's nuclear export.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Targets the spliceosome, possibly impacting the splicing regulation role of RBM29.

KPT 330

1393477-72-9sc-489062
5 mg
$173.00
(0)

Inhibits XPO1/CRM1, potentially altering RBM29's nuclear-cytoplasmic transport.

Silvestrol

697235-38-4sc-507504
1 mg
$920.00
(0)

Inhibits eIF4A, part of the translation initiation complex, potentially affecting RBM29's mRNA targets.